Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3180360 | 0.83 | KDM4E (0.40) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL1975023 | 0.79 | KDM4E (0.46) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL18470343 | 0.79 | ALDH1A1 (0.36) | KDM4EALDH1A1MEN1KMT2APOLB | |
| SCHEMBL257634 | 0.78 | KDM4E (0.41) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL30996063 | 0.77 | KDM4E (0.44) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL4445579 | 0.77 | KDM4E (0.44) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL16195634 | 0.77 | KDM4E (0.36) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL13346247 | 0.77 | KDM4E (0.40) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL6063822 | 0.76 | KDM4E (0.35) | KDM4EALDH1A1 | |
| SCHEMBL4786418 | 0.76 | KDM4E (0.44) | KDM4EALDH1A1MEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017117483-A1 | POLYMERS DERIVED FROM NORBORNADIENE AND MALEIC ANHYDRIDE AND USE THEREOF | PROMERUS, LLC (US) | 2017-07-06 | — | — | WO | disclosed |